ESM1 and chronic kidney disease: As a result, they found that plasma endocan levels were significantly higher in CKD stage 3–4 compared to CKD stage 1–2 (131.33 [60.02–199.01] pg/ml vs. 81.78 [48.23–120.75] pg/ml, p-value = 0.034).